Analyst Recommendations

Piper Sandler analyst issues NEUTRAL recommendation for PROV on July 31, 2024 06:44AM ET. The previous analyst recommendation was Neutral.PROV was trading at $12.72 at issue of the...

July 31, 2024   PROV 0.85%

Piper Sandler analyst issues OVERWEIGHT recommendation for AX on July 31, 2024 06:45AM ET. The previous analyst recommendation was Overweight.AX was trading at $77.61 at issue of the...

July 31, 2024   AX -0.01%

Piper Sandler analyst issues OVERWEIGHT recommendation for PEN on July 31, 2024 06:42AM ET. The previous analyst recommendation was Overweight.PEN was trading at $173.09 at issue of the...

July 31, 2024   PEN 3.37%

Wells Fargo analyst issues EQUAL-WEIGHT recommendation for PEN on July 31, 2024 06:43AM ET. PEN was trading at $173.09 at issue of the analyst recommendation.The overall analyst consensus...

July 31, 2024   PEN 3.37%

Piper Sandler analyst issues NEUTRAL recommendation for ISBA on July 31, 2024 06:49AM ET. The previous analyst recommendation was Neutral.ISBA was trading at $19.85 at issue of the...

July 31, 2024   ISBA 3.98%

Piper Sandler analyst issues OVERWEIGHT recommendation for ATRC on July 31, 2024 06:51AM ET. The previous analyst recommendation was Overweight.ATRC was trading at $22 at issue of the...

July 31, 2024   ATRC 2.72%

Piper Sandler analyst issues NEUTRAL recommendation for CSR on July 31, 2024 06:47AM ET. The previous analyst recommendation was Neutral.CSR was trading at $69.02 at issue of the...

July 31, 2024   CSR 12.34%

Piper Sandler analyst issues OVERWEIGHT recommendation for BGC on July 31, 2024 06:46AM ET. The previous analyst recommendation was Overweight.BGC was trading at $8.93 at issue of the...

July 31, 2024   BGC -1.40%

Piper Sandler analyst issues OVERWEIGHT recommendation for EQR on July 31, 2024 06:50AM ET. The previous analyst recommendation was Overweight.EQR was trading at $69.57 at issue of the...

July 31, 2024   EQR 1.65%

Citigroup analyst issues SELL recommendation for CHTR on July 31, 2024 06:50AM ET. The previous analyst recommendation was Sell.CHTR was trading at $383.07 at issue of the analyst...

July 31, 2024   CHTR -0.58%